Chai Hoon Quek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chai Hoon Quek has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Alejandro Chavez
Department of Pediatrics, University of California San Diego, La Jolla, CA 92037
1 shared publication- Cathleen M. Lutz
Rare Disease Translational Center, The Jackson Laboratory, Bar Harbor, USA
1 shared publication Chun-Wei Chi
Department of Pharmaceutical Sciences, University at Buffalo, the State University of New York, Buffalo, NY 14214
1 shared publication- Elisa Evgenia Konofagou
Department of Biomedical Engineering, Columbia University, New York, USA
1 shared publication Ethan Saville
The Jackson Laboratory, Bar Harbor, ME 04609
1 shared publicationHairong Zhang
Department of Biomedical Engineering, Columbia University, New York, NY 10027
1 shared publication
Latest Publications
- Open Access
- 14 August 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (34)
Focused ultrasound–mediated brain genome editing
Gene editing in the brain has been challenging because of the restricted transport imposed by the blood–brain barrier (BBB). Current approaches mainly rely on local injection to bypass the BBB. However, such administration is highly invasive and not amenable to treating certain delicate regions of the brain. We demonstrate a safe and effective gene editing technique by using focused ultrasound (FUS) to transiently open the BBB for the transport of intravenously delivered CRISPR/Cas9 machinery to the brain.
- 14 August 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (34)
Open AccessFocused ultrasound–mediated brain genome editing
Gene editing in the brain has been challenging because of the restricted transport imposed by the blood–brain barrier (BBB). Current approaches mainly rely on local injection to bypass the BBB. However, such administration is highly invasive and not amenable to treating certain delicate regions of the brain. We demonstrate a safe and effective gene editing technique by using focused ultrasound (FUS) to transiently open the BBB for the transport of intravenously delivered CRISPR/Cas9 machinery to the brain.